Europe coenzyme Q10 market to exhibit substantial growth by virtue of increased demand from cosmetic applications

The Europe coenzyme Q10 market is projected to attain a revenue share worth over $95 million by 2026 on account of a growing demand originating from the cosmetics industry. The vitamin-like substance is used in the formulation of cosmetic products including anti-aging creams, body lotions, and numerous other skin-care products. In the post-COVID scenario, the demand for these cosmetic products is expected to multiply dramatically due to the growing inclination to spend on self-care and grooming. The antioxidant properties of coenzyme Q10 have been primarily responsible for its growing deployment across the sector.  

Request a sample of this research report @

The high antioxidant content of coenzyme Q10 not only enables nourishment of the skin cells but also enhances blood circulation. Consequently, manufacturers of ointments, sunscreens, toners, creams, and gels have been using the substance as a key ingredient. Coenzymes also perform the function of Vitamin E, a crucial component in cosmetic products, acting as a preservative and emulsifier. In its powdered form, the substance is used in the manufacturing of face masks and anti-aging creams. To this end, the coenzyme Q10 industry share in Europe from the cosmetic segment is anticipated to surge at a 10% CAGR between 2020 and 2026.

Triggered by the proximity of numerous industry leaders, the coenzyme Q10 market in the UK is expected to seize a substantial portion of the overall Europe market through the forecast timeframe. The growing percentage of geriatric population, increasing per capita incomes, increased tendency to spend on health & wellness, and the existence of a robust medical sector have also been furthering the expansion of the Europe coenzyme Q10 market. The region also boasts the presence of a strong personal care industry considering the high degree of consciousness regarding appearance amongst the population.

Furthermore, coenzyme Q10 is used in multiple application areas across the pharmaceutical industry. Growing at a high CAGR of over 9.5% through the upcoming timeframe, the pharmaceutical application segment is projected to collect more than $28 million by 2026. The substance is being utilized in the production of lovastatin, atorvastatin, pravastatin, and several other drugs that aid lipid reduction and minimize cholesterol levels in the body.

Coenzyme Q10 is utilized in the treatment of heart conditions including heart cancers, congestive heart failures, and high blood pressure. It also assists in the regulation of energy metabolism, boosting the performance of the immune system. Additionally, it is also incorporated in pharmaceutical products for managing and treating diabetic conditions, mitochondrial cell disease, Parkinson’s, and migraine attacks.

Furthermore, management of heart-related conditions is attainable due to coenzyme Q10. It can ensure protection against cell damage apart from performing metabolic activities including energy conversion and synthesis. The growth of the pharmaceutical segment is expected to directly contribute toward the advancement of the Europe coenzyme Q10 market trends.  

Make an inquiry for purchasing this report @

PharmaEssentia Corporation, Avon Products, Kaneka Corporation, GlaxoSmithKline, Natural Organics, ZMC LLC, Vitamin Shoppe, Nordic Naturals, Oriflamme, and DSM are a few leading industry leaders in the Europe coenzyme Q10 market.


Table of content:

Table of content:

Chapter 1   Methodology And Scope

1.1    Research Methodology

1.2    List of data sources

1.2.1    Primary

1.2.2    Secondary

Chapter 2   Market Snapshot

2.1    Europe automotive lightweight materials market snapshot

Chapter 3   Europe Automotive Lightweight Materials Trends

3.1    Industry coverage

3.2    Industry size and forecast, 2016 – 2026

3.3    Value chain analysis

3.3.1    Company product snapshot

3.4    Innovation landscape

3.5    Regulatory norms & directives

3.6    Drivers & restraints

3.6.1    Market drivers

3.6.2    Market restraints

3.7    COVID-19 impact on industry

3.7.1    Optimistic

3.7.2    Pessimistic

3.7.3    Realistic

3.8    Industry analysis – Porter’s

3.9    Product growth mapping

3.10    Competitive benchmarking, 2019

3.10.1    Strategy dashboard

3.11    PESTLE analysis

Request for an in-depth table of contents for this report @